| Product Code: ETC334141 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Mumps Vaccine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Mumps Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Mumps Vaccine Market - Industry Life Cycle |
3.4 United States (US) Mumps Vaccine Market - Porter's Five Forces |
3.5 United States (US) Mumps Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 United States (US) Mumps Vaccine Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 United States (US) Mumps Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination and prevention of mumps |
4.2.2 Government initiatives and programs promoting vaccination and immunization |
4.2.3 Growing incidences of mumps outbreaks and the need for vaccination to control the spread |
4.3 Market Restraints |
4.3.1 Concerns and misinformation about vaccine safety and side effects |
4.3.2 High vaccine costs and lack of affordability for some segments of the population |
4.3.3 Regulatory challenges and stringent approval processes for new vaccines |
5 United States (US) Mumps Vaccine Market Trends |
6 United States (US) Mumps Vaccine Market, By Types |
6.1 United States (US) Mumps Vaccine Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Mumps Vaccine Market Revenues & Volume, By Age Group, 2021 - 2031F |
6.1.3 United States (US) Mumps Vaccine Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.1.4 United States (US) Mumps Vaccine Market Revenues & Volume, By Adult, 2021 - 2031F |
6.2 United States (US) Mumps Vaccine Market, By Distribution channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Mumps Vaccine Market Revenues & Volume, By Hospitals Pharmacies, 2021 - 2031F |
6.2.3 United States (US) Mumps Vaccine Market Revenues & Volume, By Drug Stores, 2021 - 2031F |
6.2.4 United States (US) Mumps Vaccine Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
7 United States (US) Mumps Vaccine Market Import-Export Trade Statistics |
7.1 United States (US) Mumps Vaccine Market Export to Major Countries |
7.2 United States (US) Mumps Vaccine Market Imports from Major Countries |
8 United States (US) Mumps Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population groups |
8.2 Number of reported mumps cases and outbreaks in the US |
8.3 Percentage of healthcare providers recommending mumps vaccination to eligible individuals |
8.4 Investment in research and development of new mumps vaccines |
8.5 Public perception and trust in mumps vaccination efficacy and safety |
9 United States (US) Mumps Vaccine Market - Opportunity Assessment |
9.1 United States (US) Mumps Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 United States (US) Mumps Vaccine Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
10 United States (US) Mumps Vaccine Market - Competitive Landscape |
10.1 United States (US) Mumps Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Mumps Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here